Gene Solutions Announces SPOT MAS Multi-omic Dataset on 75 Cancer Subtypes

Singapore, 26 September 2025 SPOT-MAS is Gene Solutions’ AI-powered cfDNA platform for multi-cancer early detection (MCED) and tumor-of-origin (TOO) localization across 10 cancer groups—integrating genetics, epigenetics, and fragmentomics in one streamlined workflow. Validated across multiple cancer types, the company today unveils